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Abstract
Bardet-Biedl Syndrome (BBS, MIM#209900) is a genetically heterogeneous disorder with pleiotropic phenotypes that
include retinopathy, mental retardation, obesity and renal abnormalities. Of the 15 genes identified so far, seven encode
core proteins that form a stable complex called BBSome, which is implicated in trafficking of proteins to cilia. Though BBS9
(also known as PTHB1) is reportedly a component of BBSome, its direct function has not yet been elucidated. Using
zebrafish as a model, we show that knockdown of bbs9 with specific antisense morpholinos leads to developmental
abnormalities in retina and brain including hydrocephaly that are consistent with the core phenotypes observed in
syndromic ciliopathies. Knockdown of bbs9 also causes reduced number and length of cilia in Kupffer’s vesicle. We also
demonstrate that an orthologous human BBS9 mRNA, but not one carrying a missense mutation identified in BBS patients,
can rescue the bbs9 morphant phenotype. Consistent with these findings, knockdown of Bbs9 in mouse IMCD3 cells results
in the absence of cilia. Our studies suggest a key conserved role of BBS9 in biogenesis and/or function of cilia in zebrafish
and mammals.
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Introduction
The cilium is a specialized organelle projecting from plasma
membrane of most polarized cell types in vertebrates [1,2]. The
cilium develops from the basal body that is in turn derived from
the mother centriole and participates in many fundamental
signaling pathways, including those associated with sonic hedge-
hog [3], Wnt [4] and planar cell polarity (PCP) [5]. The vertebrate
cilium is estimated to contain over 1000 proteins for its structural
and/or functional integrity [6] (http://www.ciliaproteome.org).
Defects in cilia biogenesis are associated with pleiotropic
syndromic phenotypes, collectively referred as ciliopathies; these
include Bardet-Biedl Syndrome (BBS), Meckel-Gruber Syndrome
(MKS), Joubert Syndrome (JBTS), and Nephronophthesis (NPHP)
[7].
Bardet-Biedl syndrome (MIM#209900) is typically an autoso-
mal recessive disorder that exhibits variable expressivity and
phenotypes including retinopathy, mental retardation, obesity,
polydactyly, and renal abnormalities [8,9]. Mutations in fifteen
genes are reported to account for 80% of the BBS cases [9,10]; a
few of these are also associated with the pathogenesis of related
ciliopathies. Despite tremendous genetic heterogeneity, all BBS
proteins are localized to centrosome, basal body or the ciliary
transition zone [9,11,12,13,14,15]. Investigations using mouse and
zebrafish models have demonstrated the cilia-associated functions
of BBS8, BBS4 and other BBS proteins [5,13,16,17]. Similarities
in clinical phenotypes and cellular localization have suggested
interaction(s) among different BBS proteins and their participation
in cilia biogenesis, signaling or transport. Identification of two
multiprotein complexes that include BBS proteins has provided
key biochemical and functional insights into cilia biology and
disease. BBSome, a stable complex of seven core BBS proteins
(BBS1, BBS2, BBS4, BBS5, BBS7, BBS8, BBS9) is implicated in
cilia trafficking and biogenesis [18], whereas the chaperonin
complex (comprising of BBS6, BBS10, and BBS12) seems to
mediate the assembly of BBSome [19].
BBS9 (also called PTHB1) was originally identified by
differential display analysis as a gene (B1) down regulated by
parathyroid hormone (PTH) in an osteoblastic cell line [20].
Multiple variant isoforms of PTHB1 are expressed in different
tissues, and the gene is interrupted in a translocation associated
with Wilms’ Tumor 5 [21]. More recently, haplotypes in the
region of PTHB1 have been associated with the pathogenesis of
premature ovarian failure, a complex multifactorial disease that
causes female infertility [22]. Independent genetic studies,
involving comparative mapping and gene expression analysis,
led to the identification of PTHB1 as a novel BBS gene – BBS9
[23]. Mutations in BBS9 account for 6% of BBS mutations [9].
Though BBS9 protein is shown to be a part of BBSome core
[18], its precise physiological function is not delineated, and the
mechanism of disease pathogenesis caused by BBS9 mutations is
poorly understood [23]. The zebrafish (Danio rerio) has been used as
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involving ciliary protein functions, by knockdown using morpho-
lino (MO) technology [16]. Knockdown of many cilia genes in
zebrafish are reported to cause developmental abnormalities in the
eye, brain and somites [24,25,26]. Here we report that bbs9
knockdown results in ciliogenesis defects in zebrafish and in mouse
IMCD3 cells.
Results
A BBS9 ortholog is expressed in the zebrafish during
development
In order to test the in vivo function of bbs9 using zebrafish, we
first identified the zebrafish ortholog of human BBS9 gene
(NM_198428) using available resources from GenBank
(XM_002664792.1), Zfin (AL845419) and GENESCAN program
(http://genes.mit.edu/GENESCAN.html). The predicted tran-
script codes for a protein of 904 amino acids that shows 63%
identity and 79% similarity with human BBS9 protein (Fig. 1A, B).
A multi-species comparison of BBS9 protein sequences revealed
high level of conservation from exons 2 to 8 among human, mouse
and zebrafish (Fig. 1B). Furthermore, the region of zebrafish bbs9
on chromosome 16 is syntenic with the human BBS9 locus on
chromosome 7. Currently, there is no evidence for additional
copies of bbs9 in zebrafish genome.
To analyze the expression of bbs9 during development, we
generated a partial cDNA spanning exons 2–5 by RT-PCR from
72 hour post-fertilization (hpf) embryos. In situ hybridization with
antisense mRNA probe generated from this cDNA to 11 hpf
zebrafish embryos showed almost ubiquitous expression (Fig. 1C);
however, by 15 hpf, bbs9 expression became restricted to the
anterior portion of the embryo (Fig. 1D). At 48 hpf, bbs9
transcripts were expressed in high levels in eyes and brain, while
the somites displayed low level expression (Fig. 1E).
Validation of bbs9 morpholinos
As the only known missense mutation in BBS9 patients is in
exon 5 and another frame-shift mutation in intron 4 affected exon
5 [23], we designed an exon-skipping morpholino (bbs9-spMO)
targeting the intron 4:exon 5 boundary of zebrafish bbs9 gene
(Fig. 1A, red underline). To examine whether bbs9-spMO indeed
blocked splicing, we performed RT-PCR analysis using RNA from
control-MO and bbs9-spMO injected morphants (Fig. 2C). A
single 575 bp wild type RT-PCR product was observed in control-
MO injected morphants, whereas in bbs9-spMO injected mor-
phants a shorter product (461 bp, presumably generated by exon 5
skipping, termed e5skip) was detected in addition to the 575 bp
band (Fig. 2C). The presence of two bands in the latter indicated
an incomplete effect of bbs9-spMO in the morphants.
bbs9 knockdown causes developmental defects in
zebrafish
Microinjection of bbs9-spMO into wild type embryos resulted in
severe morphogenesis defects (Fig. 2). At 48 hpf, embryos injected
with 1 ng bbs9-spMO showed a striking defect in the eye and a
conspicuous hydrocephaly in most cases (Fig. 2B, middle panels).
In initial studies with the bbs9-spMO extensive cell death was seen
at 24 hpf and there was dose dependent malformation of the trunk
and tail (Fig. 2A). As some morpholinos are known to produce p53
dependent cell death [27], we co-injected p53-atgMO to
determine if this cell death is responsible for a subset of the
observed phenotypes. In embryos co-injected with 1 ng bbs9-
spMO and 1.5 ng p53-atgMO, trunk and tail malformations was
suppressed (Fig. 2A, bottom panel) compared to embryos injected
with bbs9-spMO only (Fig. 2A, middle panel). However, reduction
in the size of the eye and hydrocephaly was consistently observed
at 48 hpf in embryos co-injected with p53-atgMO (Fig. 2B, middle
row, right panel), and a statistically significant reduction in eye size
was seen at 48 and 72 hpf (Fig. 2D), confirming that these changes
are bona fide effects of reduced bbs9 function. The bbs9-spMO
morphant phenotype observed with p53-atgMO co-injection is
reminiscent of what has been reported for BBS patients with
clinical manifestations in multiple organs - including eye and brain
(see MIM ID #209900).
To confirm the results obtained using the splice blocking bbs9
morpholino, we designed a bbs9-atgMO to target the first
translational initiation site, aug, in the predicted zebrafish bbs9
open reading frame (Fig. S1). After 48 hpf, bbs9-atgMO injected
morphants, co-injected with p53-atgMO, displayed a similar
reduction in eye size (data not shown) though, overall, bbs9-
atgMO injected morphants displayed a slightly milder phenotype,
with no hydrocephaly.
Human BBS9 mRNA rescues bbs9 knockdown phenotype
in the zebrafish
To confirm the specificity of the bbs9-spMO morphant
phenotype, we asked whether wild type human BBS9 mRNA
could rescue the bbs9-spMO injected morphants. Co-injection of
0.3 ng bbs9-spMO along with wild type human BBS9 mRNA
rescued the morphant phenotype in a dose-dependent manner
(Fig. 3). The bbs9-spMO injection alone resulted in morphants
with reduced eye size. Co-injection of bbs9-spMO with 100 pg of
wild-type human mRNA significantly improved the eye size
(Fig. 3B, D). Analysis of RNA from the rescued zebrafish revealed
an effective splice blocking of zebrafish bbs9 transcript (data not
shown), suggesting that the phenotypic rescue was indeed by the
human mRNA.
A comparable phenotype produced by exon 5 mutation in a
BBS9 patient and by the bbs9-spMO in zebrafish prompted us to
evaluate whether BBS9 mRNA carrying the exon 5 missense
mutation (amino acid change, G141R) [23] could complement the
abnormal morphant phenotypes. As predicted, the co-injection of
100 pg of missense mutant mRNA with bbs9-spMO failed to
rescue the defects in morphants (Fig. 3C, D). Our data further
suggest that human and zebrafish BBS9 proteins are highly
conserved at the functional level.
bbs9 is required for photoreceptor and brain
development
bbs9-spMO morphants displayed developmental defects in eye
and brain, and often with hydrocephaly. These are reminiscent of
the clinical features reported in BBS patients [23,28,29].
Histological analysis of the morphants’ eyes revealed a dose
dependent effect of bbs9-spMO on photoreceptors compared to
uninjected or the control-MO injected embryos (data not shown).
To examine whether the eye and brain defects are caused by
widespread cell death, we co-injected p53-atgMO (1.5 ng) with
bbs9-spMO (1 ng). At 72 hpf, p53-atgMO morphant showed a
normal eye and brain development (Fig. 4A), whereas morphants
co-injected with bbs9-spMO and p53-atgMO showed severely
malformed eye and brain (Fig. 4B). Our results demonstrate that
the eye and brain defects are indeed bona fide effects of bbs9
knockdown.
In p53-atgMO, the retina displayed proper lamination with all
five layers (Fig. 4, C). The photoreceptors’ outer segments were
clearly visible (Fig. 4C, circle) abutting the retinal pigment
epithelium (RPE). In contrast, co-injection of bbs9-spMO caused
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(Fig. 4D). The photoreceptor layer was indistinguishable from
RPE, which often displayed denudation from the inner retinal
layer due to lack of photoreceptor outer segments (Fig. 4D, circle).
The morphants did not develop a full size eye as in the controls
(Fig. 4A, B). Absence of properly formed photoreceptors,
Figure 1. Zebrafish bbs9 gene: structural comparison and expression pattern. (A) A comparison of BBS9 exon:intron structure between
human (H. sapiens, top blue), mouse (M. musculus, middle black) and zebrafish (D. rerio, bottom gray/black). The filled and open boxes indicate coding
exons and UTRs, respectively. The blue and black boxes represent validated exons. The gray boxes represent exons present in provisional sequence
XM_002664792.1. Exons 2 to 8 are highly conserved across species (boxed area within hatched square). The yellow arrow points to yellow mark on
exon 5, which represents the missense mutation GRA (p.G141R) in human BBS9 protein. Under the zebrafish bbs9 transcript, the red line represents
bbs9-spMO targeting site at intron4:exon5 boundary. (B) The protein sequence alignment (clustalW) between human (NP_940820.1), mouse
(NP_848502.1) and predicted zebrafish BBS9 (904 amino acids). Exon 5 is highlighted (yellow), and the position of missense mutation (p.G141R) in
human is highlighted by a black rectangle. The bar coding on top of the sequences represents degree of conservation (red and blue represent
maximum and minimum conservation, respectively). (C, D) In situ hybridization analysis at 11 hpf and 15 hpf. Left and right panels represent the
sense and anti-sense probes generated from bbs9 cDNA. (E) In situ hybridization analysis at 48 hpf. Expression of bbs9 in the eye, brain and somites
gives a strong signal with the anti-sense probe compared to the background signal from the sense probe. Compare the strong signal in the head
regions (arrows). Left and right panels represent lateral and dorsal views, respectively.
doi:10.1371/journal.pone.0034389.g001
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PLoS ONE | www.plosone.org 3 March 2012 | Volume 7 | Issue 3 | e34389Figure 2. Exon 5-targeted bbs9 splice morpholino affects eye development independent of p53 pathway. (A) At 24 hpf, the p53-atgMO
(1.5 ng) alone injection did not elicit a phenotype. The bbs9-spMO (1 ng) injection alone caused developmental defects in the eye, brain and tail of
morphants. However, co-injection of p53-atgMO reduced the defects seen by the bbs9-spMO injection alone, though mild eye defect remained the
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cilia function in the bbs9-spMO morphants.
We then examined the morphant brain anatomy because of the
hydrocephaly, a known sign of ciliary abnormality in the ventricles
[26,28]. Histological analysis of the morphants revealed an effect
of bbs9-spMO on brain structure. At 72 hpf, the p53-atgMO
morphants showed normal closed neural tube (Fig. 4A, E),
whereas the addition of bbs9-spMO resulted in failure of complete
neural tube closure (Fig. 4B, F, arrow). Ciliary dysfunction is one
of the reasons for incomplete neural tube closure as seen in some
of the ciliary mutants [30].
The preceding data prompted us to evaluate whether bbs9
knockdown affected the cilia in Kupffer’s vesicle (KV; Fig. 5A), a
structure often afflicted by ciliary dysfunction. We stained
morphant (injected with either control-MO or bbs9-spMO
0.3 ng) KV cilia with antibodies against acetylated alphaa-tubulin
and gammac-tubulin. The number of cilia was reduced in bbs9-
spMO injected morphants compared to control-MO injected
morphants (Fig. 5B, C). In bbs9-spMO injected morphants, the
cilia were less in number and of shorter length compared to the
cilia in control-MO injected morphants (Fig. 5D, E). These data
further show that cilia biogenesis is compromised in bbs9-spMO
morphants.
BBS9 participates in cilia biogenesis in IMCD3 cells
To further validate the contribution of BBS9 to cilia function,
we took advantage of an in vitro ciliogenesis assay using IMCD3
cells, which normally grow cilia. Knockdown of Bbs9 using mouse
specific shRNA constructs negatively affected ciliogenesis in
IMCD3 cells, resulting in more cells with no cilia compared to
the control transfection (Fig. 6A, B; Fig. S2). Some of the
transfected cells retained their cilia but these were relatively
shorter than the controls (Fig. 6B). As BBS9 interacts with BBS8 in
biochemical assays [18], knockdown of Bbs8 also resulted in similar
defects in IMCD3 cells (Fig. 6A, B; Fig. S2). The mouse Bbs9
knockdown data is in concordance with bbs9-spMO morphant KV
cilia results (see Fig. 5D, E).
Discussion
Pioneering studies during the last decade have begun to
delineate the molecular pathways leading to BBS and other
ciliopathies. As BBS patients share similar clinical features, it is
believed that BBS proteins function through common molecular
pathways. The existence and interdependence of multimeric BBS
protein complexes and their influence on ciliogenesis further
supports this view. BBS9 is a component of the BBSome complex
and reportedly interacts with several BBS proteins [18]. Our
studies provide strong evidence in support of the role of BBS9 in
cilia development as its knockdown results in BBS-like syndromic
phenotype in zebrafish. An orthologous human BBS9 mRNA
rescued the morphant phenotype, but a mutant mRNA (carrying a
missense change observed in a BBS9 patient) failed to provide
functional complementation, suggesting an evolutionary conser-
vation of BBS9 function.
In humans, a total of seven mutations have been reported in the
BBS9 gene [23]; all are homozygous except one, a compound
heterozygote. Our data show the functional conservation of BBS9
protein domain that includes the missense mutation during
evolution. However, additional investigations will be necessary to
identify the consequence of other known human mutations within
the conserved region of zebrafish bbs9.
tail becomes normal (bottom panel). (B) Higher magnification of morphants’ head region. Top, middle and bottom rows are 24-, 48- and 72-hpf,
respectively. Left and right column of panels are p53-atgMO without and with bbs9-spMO, respectively. At 48 hpf the effect of bbs9-spMO injection
on eye size visible (compare the arrows). The bbs9-spMO injection also resulted in hydrocephalous (compare the arrow heads). The defects seen at
48 hpf are weaker at 72 hpf. (C) The gel photograph of RT-PCR showing exon-skipping by bbs9-spMO. mRNA isolated from individual embryos was
used for RT-PCR. U, C (4 and 6 ng) and B (1, 4, 6 ng) represent un-injected, control, and bbs9-spMO, respectively. Splice blocking gave an additional
smaller (marked e5skip) band along with the original WT band. The bottom panel shows b-actin control for respective samples. (D) Quantification of
the effect of morpholino(s) injection on eye size. X-axis shows the morpholinos used and time (hpf) of scoring. Y-axis shows eye size in pixels (mean 6
SEM).
doi:10.1371/journal.pone.0034389.g002
Figure 3. Human mRNA rescues zebrafish bbs9-spMO pheno-
type. hW and hM represent wild type and mutant human mRNA,
respectively. The arrows indicate eye phenotype. (A) The uninjected
control (top) and bbs9-spMO alone injected (bottom) zebrafish at
72 hpf. (B) Rescue of bbs9-spMO eye phenotype by hW 100 pg (top),
but not by lower dose of 50 pg (bottom). (C)T h ebbs9-spMO
phenotype is not rescued by hM as the eye defect remains in the
morphants. (D) The quantification of embryos’ eye size at 72 hpf in
rescue experiment using human mRNAs co-injected with bbs9-spMO. X-
axis shows category of embryos scored. Y-axis shows the eye size in
pixels. Data are presented as mean 6 SEM. Statistically significant and
non-significant observations are indicated with p value and n.s.,
respectively.
doi:10.1371/journal.pone.0034389.g003
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syndromic phenotype. BBS9 is required for the assembly of the
BBSome [18], which in turn is needed for targeting membrane
proteins to the cilium [31]. Hence, loss of (or severely reduced)
function of BBS9 could affect the integrity of the BBSome complex
and compromise cilia function. Our KV cilia data demonstrate
that like many other BBS genes, Bbs9 is required for cilia
development [32]. The defective cilia in KV can affect the left-
right laterality [32]. Since we did not analyze heart looping or
laterality markers it remains to be tested whether bbs9 morphants
have any laterality defects. The retinal degeneration in zebrafish,
exhibited by bbs9-spMO morphants, is a further indication of cilia
dysgenesis similar to the phenotype produced by Rpgr knockdown,
which causes abnormal ciliary transport [33].
BBS patients suffer varying degrees of cognitive dysfunctions
[34], possibly due to dyskinesia [35] and subsequent development
of hydrocephalus, observed in BBS3 patients [29] and its rodent
models [36]. Similar phenotypes are reported in rodents [28,37]
and in zebrafish [26]. Thus, the hydrocephaly in bbs9-spMO
morphant could be attributed to ciliary dyskinesia. Hydrocephaly
in bbs9-spMO morphants suggested a possible ciliary abnormality
in the ventricles and ependymal canal. However, we did not
analyze the cilia in these structures. bbs9-spMO morphants show
defects in neural tube closure, which could be due to defective
non-canonical Wnt (PCP) pathway mediated via Vangl2 [38].
Mice having mutations in BBS1, BBS4 or BBS6 reportedly display
a phenotype resembling a mutation in Vangl2, which includes
neural tube defects [30]. Interestingly, VANGL2 and BBS proteins
co-localize in the basal body and ciliary axoneme [5]. We
therefore propose that bbs9 knockdown results in ciliary dysfunc-
tion in the morphants, resulting in open neural tubes.
Several components of the BBSome are critical for ciliogenesis.
The roles of BBS1, BBS5, and BBS8 in ciliogenesis have been
demonstrated in RPE cells [18,39]. BBS9 has been shown to
interact with BBS1 and BBS8, with variable strength [18]. Though
an earlier ciliogenesis assay using RPE cells showed a weak effect
of BBS9 siRNA [39], our assay using IMCD3 cells and BBS9
shRNA conclusively demonstrated that BBS9 is required for the
development of cilia. Defects in cilia function can account for
abnormalities in eye and brain of bbs9-spMO morphants. Notably,
an association between an amino acid change in PTHB1 and
premature ovarian failure in human has been reported [22]. The
exact pathogenic mechanism is unclear; however, ciliary dysfunc-
tion has been associated with ovarian function [40].
In summary, we provide in vivo evidence of bbs9 function in cilia
biogenesis and/or transport. Loss of BBS9 leads to defects in
organogenesis, presumably because of its crucial role in BBSome
assembly and cilia formation. Further investigations are necessary
to elucidate the precise biochemical role of BBS9 within the
BBSome complex and in cilia biogenesis and/or function.
Materials and Methods
Morpholino injections in zebrafish
Fluorescein-tagged morpholinos (MOs) were procured from
Gene Tools Inc. (OR, USA). A standard negative control (control-
MO), p53-atgMO (59- GCGCCATTGCTTTGCAAGAATTG -
39) and custom-designed translation blocking (bbs9-atgMO - 59-
CGCTGAAGCCAGAACTGTGGAACAT - 39) and splice
blocking (bbs9–spMO - 59-CGGTGCCTGAGAAAACCATACA-
TAT - 39) MOs against zebrafish bbs9 were obtained in lyophilized
form, re-suspended in distilled water, and quantified spectropho-
tometrically (NanoDrop Tech Inc, DE, USA).
Figure 4. bbs9-spMO morphant shows defects in retina
lamination and neural tube closure. Zebrafish head sections
(72 hfp) stained with H& E. (A) The morphant injected with p53-atgMO
(1.5 ng) shows normal retinal lamination and neural tube (areas
highlighted with hatched yellow rectangles). (B) The morphant co-
injected with bbs9-spMO (1 ng) and p53-atgMO (1.5 ng) shows lack of
retinal lamination and incomplete closure of neural tube (areas
highlighted with hatched yellow rectangles). (C) The morphant retina
in higher magnification - area boxed in ‘A’. The retina shows all the 5
layers: Retinal pigment epithelium (RPE) abutting close to photorecep-
tors (PRs). The PRs (hatched circle) have visible outer segments (OS).
Next to PRs are the outer nuclear layer (ONL) followed by an intact inner
nuclear layer (INL) and the ganglion cell layer (GCL). The optical nerve
(ON) is used as a reference point. (D) The bbs9-spMO injected morphant
retina in higher magnification - area boxed in ‘B’. The retina shows no
clear lamination and it lacks photoreceptor outer segments (hatched
circle). (E) The morphant neural tube in higher magnification from ‘A’
shows normal closure (arrow). (F) The bbs9-spMO injected morphant
neural tube in higher magnification from ‘B’ shows incomplete closure
of neural tube (arrow). The scale bars indicate 100 mm.
doi:10.1371/journal.pone.0034389.g004
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National Institutes of Health animal use protocol. Staged wild type
embryos of EK strain between 2–8 cells were microinjected 0.4–
1.2 nL of morpholinos into the yolk sac using pneumatic pico pump
(WPI, FL, USA). Before injection, a fresh glass capillary needle was
pulled with Kopf needle/pipette puller (Model 750, Tujunga, CA,
USA), and calibrated against a micrometer to determinethe volume
delivered per pulse. Microinjected embryos were incubated at 28uC
overnight and scored for survival the following day. Live embryos
were ascertained of successful injection by fluorescein signal and
followed until 48–72 hpf to observe any overt phenotype under
Leica Microscopes MZ16F and ICA (Leica Microsystems, IL,
USA). Phenotypes were captured with Leica DC500 camera
attached to Leica microscope MZ16F (total magnification em-
ployed: 0.636 646 or 86). Eye size was determined by imaging
embryos on a Zeiss Axioskop upright microscope using a 106
objective. Total eye area in pixels wasquantified in imageJ using the
known scaling factor for this objective. p values were obtained using
students t-test (two tailed, unpaired).
mRNA isolation, RT-PCR and verification of bbs9
sequence
Total RNA was extracted from individual embryos at 72 hpf with
Trizol Reagent (Invitrogen, CA, USA). RNA sample (200 ng) was
reverse transcribed with random primers using Superscript III
(Invitrogen, CA, USA.). The cDNA was then amplified according to
standardprotocol using Taq polymerase (New England Biolabs, MA,
USA). The following PCR primers were used for splice verification:
59-TTTGTTTAAGGCCCGTGATT-39 and 59-TGAAG-
GAGTCTGTGCGAATG-39. Exon 1 to 5 were generated by
PCR using primers: 59-ATGTTCCACAGTTCTGGCTTCAG-
39 and 59-CTGTAACACCACCGAATGGGCCATA-39, and the
PCR product was TA cloned in pGEMTEasy (Promega Corp,
WI, USA). The presence of exons 2 to 5 in pGEMTEasy was
verified (Fig. S1) by sequencing using T7 primer.
In vitro RNA preparation for rescue and mutation
synthesis
For rescue experiment, a human BBS9 full-length cDNA (Clone ID
5519851) was obtained from Open Biosystems (AL, USA) and
sequence-verified. To recreate the missense mutation (G141R) in
human BBS9 protein, a corresponding wild type zebrafish nucleotide
was subjected to site-directed mutagenesis using QuikChange II kit
(Stratagene; Agilent Tech, CA, USA). The wild type and mutant
cDNA from SPORT6 were subcloned into pcDNA3.1(+)v e c t o ra t
EcoRV-XhoI sites. Subcloned cDNAs were linearized with XmaI and
used for in vitro synthesis of capped mRNA using mMESSAGE
mMACHINE T7 Ultra Kit (Ambion, Applied Biosystems, CA, USA).
The quality of in vitro synthesized mRNA was checked on Bioanalyser
(Agilent Tech, CA, USA) before co-injection with bbs9-spMO.
Figure 5. Knockdown of bbs9 affects cilia in Kupffer’s vesicle. (A) Schematic view of Kupffer’s vesicle (KV) in zebrafish embryo at 12 hpf. A, P,
D and V indicate anterior, posterior, dorsal and ventral sides, respectively. (B) Morphant injected with control-MO (0.3 ng). (C) Morphant injected with
bbs9-spMO (0.3 ng). In the morphants, KV cilia were visualized by staining with both anti-a-tubulin and anti-c-tubulin (green), between 10–13 hpf. In
‘B’, cilia are more in number and are longer (cf. white arrows) than in ‘C’. In B and C, upper panels show the nuclei visualized with DAPI. (D) and (E)
show quantification of KV cilia number and length, respectively. The Y-axis represents the mean 6 SEM. The X-axis represents the indicated category
of morphants analyzed.
doi:10.1371/journal.pone.0034389.g005
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RT-PCR product corresponding to zebrafish bbs9 was cloned into
pGEMT-easy (Promega Corp, WI, USA) and sequence-verified. The
vector was linearized with Sal I or Nco I and used to generate the sense
(T7 RNA polymerase) or antisense (SP6 RNA polymerase) probes,
respectively, with DIG RNA labeling Mix (Roche Applied Science,
IN, USA). In situ hybridization was performed as described [41].
H&E staining of eye and brain
At 72 hpf, zebrafish larvae were fixed with 4% glutaraldehyde
for 30 min at RT, then fixed with 4% paraformaldehyde (PFA)
overnight at 4uC. Subsequently, they were washed with PBS and
embedded in OCT compound Tissue-Tek (SakuraFinetek USA,
Inc, CA, USA) and 10 mm sections were cut. The sections were
stained with standard H&E staining protocol.
Figure 6. Knockdown of Bbs9 affects ciliogenesis in IMCD3 cells. (A) Bbs8 and Bbs9 shRNA transfection in IMCD3 cells. The top row shows
eGFP control transfection, whereas middle and bottom rows represent eGFP co-transfected with shRNA against Bbs9 or Bbs8, respectively. The nuclei
are visualized with DAPI (blue). Transfection is visualized with eGFP (green). Cilia are visualized with both anti-alpha-tubulin and gamma-tubulin (red).
shRNA transfected cells (green) have no cilia (red) - highlighted with yellow circle (broken). In the top control panel, eGFP alone-transfected cell
shows a cilium (highlighted with yellow arrows). Images are taken at 606magnification. (B) The quantification of cilia length after Bbs8 and Bbs9
shRNA transfection in IMCD3 cells (obtained from A). The X and Y axes respectively show transfection category and length (micrometer) of cilia in
eGFP transfected cells per seven fields. Data are presented as mean 6 SEM, and statistical significance is indicated with p values.
doi:10.1371/journal.pone.0034389.g006
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The embryos aged 10–13 hpf were fixed with 4% PFA and
stained with antibodies against acetylated-alpha- tubulin and
gamma-tubulin to visualize the cilia. The embryos were then
embedded in 2% low melting agarose and positioned for confocal
microscopy. The images were taken with Leica TCS SP2 using a
water immersion lens (406) and processed for maximum
projection and quantification of cilia using LCM software.
Ciliogenesis assay
Adult mouse kidney Inner Medullary Collecting Duct cells -3
(IMCD3; ATCC Number: CRL-2123; ATCC, VA, USA.) were
grown near confluence overnight on 6-well plate by seeding
200610 ˆ3 cells and transfected with 750 ng of each plasmid DNA
(eGFP and shRNA) in serum free medium using fugene6 (Roche
Applied Science, IN, USA). After 8 hr, the serum free medium
was replaced with complete medium. Twelve hr later, the cells
were washed twice for 5 min each with 0.5 mL PBS and fixed for
15 min at RT with 0.5 mL of 4% PFA in PBS. After fixation, PFA
was removed and the cells were washed twice with 0.5 mL PBS.
Subsequently, the cells were incubated at RT in 0.5 mL of 5%
normal goat serum in PBT (0.1%) for 30 min for blocking. The
cells were then incubated with 0.2 mL of a primary antibody (anti-
acetylated alpha-tubulin, Sigma -T7451 and anti-gamma-tubulin,
Sigma-T6557 (Sigma-Aldrich Corp., MO, USA), both 1:1000
diluted in blocking solution) for 1 hr at RT. Subsequently, the cells
were washed 36with 0.1% PBT for 5 min each, and incubated
with 0.2 mL secondary antibody (anti-mouse Alexa 568 (Invitro-
gen, CA, USA), 1:500 diluted in blocking solution) for 1 hr at RT.
Finally, nuclear staining was performed with 0.2 mL DAPI
(diluted 1:1000) for 5 min at RT. The cells were washed with
0.5 mL PBS twice for 5 min. The slides were mounted with
flouromount and imaged on Olympus FluoView FV1000 (Tokyo,
Japan) confocal microscope.
shRNA construct sets against mouse Bbs8 and Bbs9 were obtained
from Open Biosystems (AL, USA): (Bbs8: TRCN0000113210 - 14),
(Bbs9: TRCN0000178683; TRCN0000181485; TRCN0000182069;
TRCN0000182387; TRCN0000182647). The following shRNA
constructs gave the best knockdown results - Bbs8.3:
TRCN0000113213, and Bbs9.5 (TRCN0000182387) (shown in
Fig. 6). The presence or absence of cilia in a transfected (eGFP
alone or co-transfected with shRNA construct) cell was manually
scored under an epifluorescence microscope (Olympus, BX50F4;
406; Olympus, Japan). The raw data for all shRNA constructs are
presented in Fig. S2. The cilia length in transfected cells (eGFP,
BBS8.3 and BBS9.5) was quantified using ImageJ software.
Supporting Information
Figure S1 Validated zebrafish bbs9 sequence. The bbs9
cDNA sequences are aligned to see the degree of matching (top - t.
and the bottom - b. sequences were obtained from sequencing data
and the provisional version, respectively. The bbs9 specific product
was amplified by PCR using cDNA generated from zebrafish total
mRNA. RT-PCR and sequencing data show that exons 2 to 5 are
expressed in zebrafish. Exons 2 and 5 are highlighted in yellow;
the sequences are perfectly matched until exon 5 (indicated by red
bar on top).
(TIF)
Figure S2 Bbs8 and Bbs9 knockdown compromised
ciliogenesis in IMCD3 cells. Knockdown of Bbs8 and Bbs9
in IMCD3 cells with 4 different shRNA constructs (#1, 3, 4, 5).
Green cells represent the cells transfected with shRNA construct.
X-axis displays the analysis categories. Y-axis displays the number
of green cells. BBS8 or BBS9 shRNA construct (as indicated) was
used along with eGFP. Control transfection was performed with
eGFP (shown on the right) without any shRNA construct. Only
green cells were counted for obtaining the raw data.
(TIF)
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